How is this? Prescription Carbonyl with a stool softener component.
Ferralet 90 with Ferr-Ease™* contains both ferrous gluconate and carbonyl iron--dual-iron delivery for a unique, patented way to deliver oral iron therapy. With Ferralet 90, oral iron therapy is delivered to patients in sync with the timing of iron update. The ferrous gluconate enters the body in the ferrous form, for rapid uptake. The carbonyl iron works with the patient's gastric acid to become solubilized and absorbed by intestinal enterocytes in a gentle, prolonged manner.1
Ferralet 90 is designed for dual action and gentle action, to address traditional drawbacks of iron therapy. The complete formulation includes:
- Ferr-Ease for 90 mg dual-iron delivery
- 120 mg ascorbic acid to enhance iron absorption2
- 12 µg vitamin B12 to support red blood cell generation3
- 1 mg folic acid to bolster the development of red blood cells4
- Gentle stool softener plus a pleasing vanilla scent
- Small pill to make swallowing easier
Plus, Ferralet 90 is lactose- and gluten-free to accommodate dietary issues.
Important Safety Information
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Warning
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Precautions
Administration of Drug
- General: Take 2 hours after meals. Do not exceed recommended dose. Discontinue use if symptoms of intolerance appear. The type of anemia and underlying cause or causes should be determined before starting therapy with Ferralet® 90 tablets. Ensure Hgb, Hct, reticulocyte count are determined before starting therapy and periodically thereafter during prolonged treatment. Periodically review therapy to determine if it needs to be continued without change or if a dose change is indicated. This product contains FD&C Yellow No. 5 (tartrazine) which may cause allergic type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.
- Folic Acid: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using these products since folic acid may mask the symptoms of pernicious anemia.
- Pediatric Use: Safety and effectiveness in pediatric patients have not been established.
- Geriatric Use: Dosing for elderly patients should be cautious. Due to the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy, dosing should start at the lower end of the dosing range.
This material is intended to provide basic information. Patients should discuss all medical advice, diagnosis, and treatment with their healthcare provider.
Please see full Prescribing Information
* US Patent no. 6,521,247 B1
- Huebers HA, Brittenham GM, Csiba E, Finch CA. Absorption of carbonyl iron. J Lab Clin Med. 1986 Nov;108(5):473-8.
- Lynch SR, Stoltzfus RJ. Iron and ascorbic Acid: proposed fortification levels and recommended iron compounds. J Nutr. 2003 Sep;133(9):2978S-84S.
- Vitamin B12 [Internet]. MayoClinic.com; [cited 2009 Dec 17]. Available from http://www.mayoclinic.com/health/vitamin-B12/NS_patient-vita minb12.
- Folic acid [Internet]. WebMD; [updated 2007 Mar 5; accessed 2009 17 Dec]. Available from http://www.webmd.com/diet/folic-acid.
- Site Map
- Legal/Privacy
- Prescribing Information
- Report Adverse Event
- Contact
- Mobile Version
- Printer-Friendly Page








Home Healthcare Professionals Patient Information Iron Deficiency Anemia Press/Media